Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 18 Mar 24 EFFECT Notice of effectiveness
- 15 Mar 24 424B3 Prospectus supplement
- 6 Mar 24 S-1/A IPO registration (amended)
-
2 Feb 24 S-1 IPO registration
SEEL similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 9, 2023, with respect to the consolidated financial statements of Seelos Therapeutics, Inc., incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
February 2, 2024